Monday, February 5, 2007
On Feb. 16, 2007, the Seton Hall Law Review will host a symposium on the FDA: A Delicate Balance: The FDA's Drug and Device Regulations, Public Health, Intellectual Property and the Economy. Panels will address the FDA approval process, intellectual property and drug innovation, and the link between FDA policies and health care economics. The keynote speaker is Daniel Meron, General Counsel of the Department of Health and Human Services. The conference will take place at Seton Hall Law School in Newark, NJ.